PubMed 29301551

PubMed ID: 29301551

View on PubMed
RNA virus interference via CRISPR/Cas13a system in plants.
Authors: Aman Rashid, Ali Zahir, Butt Haroon, Mahas Ahmed, Aljedaani Fatimah, Khan Muhammad Zuhaib, Ding Shouwei, Mahfouz Magdy
Journal: Genome biology (Genome Biol), Vol.19(1), 2018‑Jan‑04

DOI: 10.1016/j.cell.2017.06.050 PMCID: PMC4653885

Abstract
CRISPR/Cas systems confer immunity against invading nucleic acids and phages in bacteria and archaea. CRISPR/Cas13a (known previously as C2c2) is a class 2 type VI-A ribonuclease capable of targeting and cleaving single-stranded RNA (ssRNA) molecules of the phage genome. Here, we employ CRISPR/Cas13a to engineer interference with an RNA virus, Turnip Mosaic Virus (TuMV), in plants.

CRISPR/Cas13a produces interference against green fluorescent protein (GFP)-expressing TuMV in transient assays and stable overexpression lines of Nicotiana benthamiana. CRISPR RNA (crRNAs) targeting the HC-Pro and GFP sequences exhibit better interference than those targeting other regions such as coat protein (CP) sequence. Cas13a can also process pre-crRNAs into functional crRNAs.

Our data indicate that CRISPR/Cas13a can be used for engineering interference against RNA viruses, providing a potential novel mechanism for RNA-guided immunity against RNA viruses and for other RNA manipulations in plants.
Publication Types
Journal Article Research Support, Non-U.S. Gov't
Keywords
CRISPR/Cas systems CRISPR/Cas13a Molecular immunity RNA interference RNA knockdown Transcriptome regulation Virus interference
Related Articles